Profile picture of PBS
COVID pill Paxlovid gets full FDA approval after over a year of pandemic emergency use
pbs.org/newshour/health/covid-pill-paxlovid-gets-full-fda-approval-after-over-a-year-of-pandemic-emergency-use
COVID pill Paxlovid gets full FDA approval after over a year of pandemic ...
Profile picture of UPI
Former Pfizer employee charged with insider trading over Paxlovid - UPI.com: A former Pfizer employee is being charged with insider trading for allegedly ...
upi.com/Top_News/US/2023/06/29/pfizer-employee-charged-insider-trading-paxlovid-covid-19/5311688083757/
Former Pfizer employee charged with insider trading over Paxlovid - UPI ...
Profile picture of CNA
Singapore's PM Lee tests positive for COVID-19: Prime Minister Lee Hsien Loong says he is feeling generally ok but is self-isolating until he is ...
channelnewsasia.com/singapore/pm-lee-hsien-loong-covid-19-positive-paxlovid-booster-vaccination-3505591
Singapore's PM Lee tests positive for COVID-19
Quick Glance: Singapore's PM Lee Tests Positive for Covid-19
  • Singapore's Prime Minister Lee Hsien Loong has tested positive for Covid-19 for the first time, he said in a Facebook post on Monday.
Profile picture of Time
Paxlovid Moves Closer to Full FDA Approval: Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers, clearing the way for full ...
time.com/6263979/paxlovid-fda-approval-covid-19/
Paxlovid Moves Closer to Full FDA Approval
Quick Glance: FDA: Rebound of COVID-19 Occurs Regardless of Paxlovid Use
  • According to FDA documents, a rebound of COVID-19 may be part of the disease's natural progression, regardless of Paxlovid treatment.

  • Paxlovid patients experienced a rebound in COVID-19 symptoms and tested positive for the virus after previously testing negative in some cases, such as with President Joe Biden and leading infectious disease expert Anthony Fauci.

  • "FDA staffers cited an analysis showing that rates of COVID-19 symptom rebound were similar between people who took Paxlovid and people who took a placebo."

  • According to the documents, overall symptom rebound rates ranged from 10 to 16%.
Profile picture of The Dallas Morning News
Covid antiviral Paxlovid approved by FDA for high-risk adults: The FDA granted full approval for adults with COVID-19 who face high risks of severe disease ...
dallasnews.com/news/2023/05/25/covid-pill-paxlovid-gets-full-fda-approval-after-more-than-a-year-of-emergency-use/
Covid antiviral Paxlovid approved by FDA for high-risk adults
Profile picture of Bloomberg
Pfizer’s Covid Sales Drop Less Than Expected as Demand Holds: Pfizer Inc.’s first-quarter profit and revenue outpaced analysts’ expectations on surprising ...
bloomberg.com/news/articles/2023-05-02/pfizer-beats-estimates-as-covid-shot-paxlovid-sales-outperform
Pfizer’s Covid Sales Drop Less Than Expected as Demand Holds
Profile picture of CNN.com
Vaccination, Paxlovid decrease risk of long Covid, studies show: People who are vaccinated or who take Paxlovid during a Covid-19 infection have a lower risk of ...
cnn.com/2023/03/23/health/long-covid-vaccination-paxlovid/
Vaccination, Paxlovid decrease risk of long Covid, studies show
Profile picture of Los Angeles Times
Opinion: Why is COVID still killing so many people? : Many immunocompromised and older Americans feel abandoned. That's a public health failure.
latimes.com/opinion/story/2023-06-05/covid-booster-deaths-protection-vulnerable-groups
Opinion: Why is COVID still killing so many people?
Profile picture of El País
Covid-19 pill Paxlovid moves closer to full FDA approval: A panel of outside experts voted 16-1 that Paxlovid remains a safe and effective treatment for ...
english.elpais.com/science-tech/2023-03-17/covid-19-pill-paxlovid-moves-closer-to-full-fda-approval.html
Covid-19 pill Paxlovid moves closer to full FDA approval
Profile picture of CNN.com
Paxlovid not linked to Covid-19 rebound, FDA says ahead of meeting to consider drug’s full approval
cnn.com/2023/03/16/health/fda-committee-paxlovid-approval/
Paxlovid not linked to Covid-19 rebound, FDA says ahead of meeting to ...
Profile picture of Scientific American
New COVID Antiviral Cuts Hospitalizations in Half: Scientific American is the essential guide to the most awe-inspiring advances in science and technology ...
scientificamerican.com/article/new-covid-antiviral-cuts-hospitalizations-in-half/
New COVID Antiviral Cuts Hospitalizations in Half
Profile picture of Reuters
Paxlovid sales forecasts may change with Pfizer view on China: Clarity from Pfizer Inc (PFE.N) this week on whether China's relaxation of its Zero-COVID policy ...
reuters.com/business/healthcare-pharmaceuticals/paxlovid-sales-forecasts-may-change-with-pfizer-view-china-2023-01-30/
Paxlovid sales forecasts may change with Pfizer view on China
Profile picture of Bloomberg
Singapore PM Turns Covid Positive Again in a Week, Feels Fine: Singapore’s Prime Minister Lee Hsien Loong has tested positive again for Covid-19 but is feeling ...
bloomberg.com/news/articles/2023-06-01/singapore-pm-turns-covid-positive-again-in-a-week-feels-fine
Singapore PM Turns Covid Positive Again in a Week, Feels Fine
Profile picture of CNBC
The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion: Sales of Paxlovid surged to $18.9 billion in 2022, which was the first full year the ...
cnbc.com/2023/01/31/the-covid-pandemic-drives-pfizers-2022-revenue-to-a-record-100-billion.html
The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion
Profile picture of Bloomberg
Pfizer 2023 Outlook Disappoints as Covid Business Drops Off: Pfizer Inc.’s 2023 forecasts fell short of analysts’ expectations on precipitously declining demand ...
bloomberg.com/news/articles/2023-01-31/pfizer-forecasts-lower-than-expected-2023-earnings-on-covid-dip
Pfizer 2023 Outlook Disappoints as Covid Business Drops Off
Profile picture of Reuters
Pfizer CEO rules out generic COVID drug Paxlovid for China: Pfizer Inc (PFE.N) is not in talks with Chinese authorities to license a generic version of its ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-not-talks-licensing-generic-covid-pill-china-2023-01-10/
Pfizer CEO rules out generic COVID drug Paxlovid for China
Profile picture of CNBC
FDA staff report says data shows Pfizer's Covid treatment Paxlovid is effective in high-risk adults
cnbc.com/2023/03/14/fda-staff-report-says-data-shows-pfizers-covid-treatment-paxlovid-is-effective-in-high-risk-adults.html
FDA staff report says data shows Pfizer's Covid treatment Paxlovid is ...
Profile picture of Bloomberg
Mysterious Boom in Italy’s Exports to China Was Driven by Pfizer Anti-Covid Drug: The mysterious boom in Italian exports to China is linked to Pfizer Inc ...
bloomberg.com/news/articles/2023-05-31/italy-export-boom-to-china-was-driven-by-pfizer-anti-covid-drug
Mysterious Boom in Italy’s Exports to China Was Driven by Pfizer ...
Profile picture of ctvnews.ca
Beijing to distribute Pfizer antiviral drug as Covid wave strains health system: Beijing will begin distributing Pfizer's COVID-19 drug Paxlovid to the city's ...
ctvnews.ca/health/coronavirus/beijing-to-distribute-pfizer-antiviral-drug-as-covid-wave-strains-health-system-1.6208986
Beijing to distribute Pfizer antiviral drug as Covid wave strains health ...
Profile picture of Wired (magazine)
The Search for Long Covid Treatments Takes a Promising Turn : Scientists believe lasting symptoms following a coronavirus infection are not a single disorder ...
wired.com/story/long-covid-treatments/
The Search for Long Covid Treatments Takes a Promising Turn
Profile picture of PBS
COVID-19 treatment Paxlovid has been free so far. Next year, sticker shock awaits
pbs.org/newshour/health/covid-19-treatment-paxlovid-has-been-free-so-far-next-year-sticker-shock-awaits
COVID-19 treatment Paxlovid has been free so far. Next year ...
Profile picture of The Globe and Mail
Antiviral drug could be an effective COVID-19 treatment for high-risk patients, study shows
theglobeandmail.com/canada/article-antiviral-drug-covid-19-high-risk/
Antiviral drug could be an effective COVID-19 treatment for high-risk ...
Profile picture of The New York Times
What to Know About Covid Tests and Treatment as the Public Health Emergency Ends: The emergency expired May 11, complicating access to tests and treatment in the ...
nytimes.com/2023/02/01/well/live/covid-public-health-emergency.html
What to Know About Covid Tests and Treatment as the Public Health ...
Profile picture of Reuters
China says talks to include Paxlovid in its insurance drug list fail: China will not include Pfizer Inc's (PFE.N) Paxlovid in an update to its list of medicines ...
reuters.com/business/healthcare-pharmaceuticals/china-says-talks-include-paxlovid-state-health-insurance-fail-2023-01-08/
China says talks to include Paxlovid in its insurance drug list fail
Profile picture of HuffPost

Paxlovid, the antiviral used to treat COVID-19, is moving closer to full approval by the Food and Drug Administration.

Profile picture of ctvnews.ca
Paxlovid medication lowers risk of COVID-19 death, hospitalization: study: A new study has found that Paxlovid is proven to lower the risk of COVID-19-related ...
ctvnews.ca/health/coronavirus/paxlovid-medication-lowers-risk-of-covid-19-death-hospitalization-study-1.6270770
Paxlovid medication lowers risk of COVID-19 death, hospitalization: study
Profile picture of The Atlanta Journal-Constitution
Experts: Underuse of COVID-19 drug Paxlovid shortchanging patients: Ira Katz bustles at his pharmacy in Little Five Points this cough season ...
ajc.com/news/coronavirus/experts-underuse-of-covid-19-drug-paxlovid-shortchanging-patients/JZB6RNR44RDELJOU6KTIJYSQCU/
Experts: Underuse of COVID-19 drug Paxlovid shortchanging patients
Profile picture of Fortune (magazine)
COVID will eventually evade one of the few treatments for those infected and could cause deaths to ‘easily double,’ former White House advisor Deborah Birx ...
fortune.com/well/2023/04/29/covid-antiviral-paxlovid-evade-deborah-birx-double-deaths/
COVID will eventually evade one of the few treatments for those infected ...
Profile picture of thedailybeast.com
FDA: Paxlovid Does Not Cause COVID ‘Rebound’: That’s according to a staff review of Pfizer’s clinical trials of the antiviral.
thedailybeast.com/fda-paxlovid-does-not-cause-covid-rebound
FDA: Paxlovid Does Not Cause COVID ‘Rebound’
Profile picture of ABC News
More than 24K people have reported COVID test results to new NIH website: There may be a bias in who is inclined to report test results, experts say.
abcnews.go.com/Health/24k-people-reported-covid-test-results-new-nih/story
More than 24K people have reported COVID test results to new NIH website
Profile picture of The New York Times
China’s Abrupt Covid Pivot Leaves Many Without Medicines: Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s ...
nytimes.com/2022/12/20/world/asia/china-covid-shortages.html
China’s Abrupt Covid Pivot Leaves Many Without Medicines
Profile picture of Time
A One-Shot COVID-19 Treatment Shows Promise: The drug interferon lambda may represent a new generation of antiviral treatment. But it will likely be available ...
time.com/6254030/single-shot-covid-19-treatment/
A One-Shot COVID-19 Treatment Shows Promise
Profile picture of Daily Breeze
What older Americans need to know about taking Paxlovid: COVID-19 continues to hit seniors with disproportionate severity. Experts say Paxlovid is an effective ...
ocregister.com/2023/01/18/what-older-americans-need-to-know-about-taking-paxlovid
What older Americans need to know about taking Paxlovid
Profile picture of Time
As COVID-19 Barrels Through China, Some Are Turning to Black Market Amid Drug Shortages
time.com/6247596/covid-china-contraband-treatments/
As COVID-19 Barrels Through China, Some Are Turning to Black Market Amid ...
Profile picture of Investor's Business Daily

From 'Darling' To Downgrade: Pfizer tumbled Wednesday after an analyst downgraded it, saying the "Covid darling" is now a "show me" story as ... Show more

Profile picture of The Hill (newspaper)
Pfizer signs deal to sell Paxlovid in China as COVID cases climb: report: Pfizer has inked a deal with a Chinese-based pharmaceutical company to sell the ...
thehill.com/policy/healthcare/3775373-pfizer-signs-deal-to-sell-paxlovid-in-china-as-covid-cases-climb-report/
Pfizer signs deal to sell Paxlovid in China as COVID cases climb: report
Profile picture of Malaysiakini
Monitoring of asymptomatic Covid-19 patients now through MySejahtera: Health DG says this will replace robocalling.
malaysiakini.com/news/650114
Monitoring of asymptomatic Covid-19 patients now through MySejahtera
Profile picture of Time
As COVID-19 Barrels Through China, Some Are Turning to Black Market Amid Drug Shortages
time.com/6247596/covid-china-contraband-treatments/
As COVID-19 Barrels Through China, Some Are Turning to Black Market Amid ...
Profile picture of Ottawa Citizen
Profile picture of english.alarabiya.net
No easy way to get Pfizer’s COVID-19 drug Paxlovid in China: When Li’s 83-year-old father with diabetes started coughing and complaining of body aches last month ...
english.alarabiya.net/News/world/2023/01/18/No-easy-way-to-get-Pfizer-s-COVID-19-drug-Paxlovid-in-China
No easy way to get Pfizer’s COVID-19 drug Paxlovid in China
Profile picture of The Philadelphia Inquirer
What older Americans need to know about taking Paxlovid: If people can’t tolerate the medication — potential complications with other drugs need to be carefully ...
inquirer.com/health/coronavirus/paxlovid-covid-treatment-need-to-know-20230124.html
What older Americans need to know about taking Paxlovid
Profile picture of CBC
Prescriptions for COVID-19 antiviral Paxlovid double in Ontario after pharmacists allowed to prescribe
cbc.ca/news/canada/toronto/ontario-pharmacy-paxlovid-1.6700306
Prescriptions for COVID-19 antiviral Paxlovid double in Ontario after ...
Profile picture of The Straits Times
China’s soaring Covid-19 cases send people to black market for medicines: They are paying huge premiums for the antivirals, such as 5,800 yuan (S$1 ...
straitstimes.com/asia/east-asia/china-s-soaring-covid-19-cases-send-people-to-black-market-for-medicines
China’s soaring Covid-19 cases send people to black market for medicines
Profile picture of The Irish Times
Fewer than 3,000 people prescribed antiviral pill that prevents them becoming seriously ill with Covid
irishtimes.com/health/2023/02/05/fewer-than-3000-people-prescribed-antiviral-pill-that-prevents-them-becoming-seriously-ill-with-covid/
Fewer than 3,000 people prescribed antiviral pill that prevents them ...
Profile picture of CNA
New Chinese antiviral pill yields promising results in recent trials amid China's COVID-19 surge
channelnewsasia.com/asia/vv116-new-antiviral-drug-pill-covid-19-china-paxlovid-3174711
New Chinese antiviral pill yields promising results in recent trials amid ...
Profile picture of Axios (website)
Questions still swirl over Paxlovid as full approval from the nears: Pfizer's antiviral Paxlovid is one step closer to gaining full approval from the Food ...
axios.com/2023/03/17/paxlovid-fda-approval-nears
Questions still swirl over Paxlovid as full approval from the nears
Profile picture of ABC News
No clear association between Paxlovid and COVID-19 rebound, FDA says: Rates are around the same in people who took the drug and those who didn't.
abcnews.go.com/Health/clear-association-paxlovid-covid-19-rebound-fda/story
No clear association between Paxlovid and COVID-19 rebound, FDA says
Profile picture of The Plain Dealer
Winter’s feared ‘tripledemic’ fizzled; new vaccines, at-home tests for flu, COVID-19, RSV on the horizon
cleveland.com/news/2023/03/winters-feared-tripledemic-fizzled-new-vaccines-at-home-tests-for-flu-covid-19-rsv-on-the-horizon.html
Winter’s feared ‘tripledemic’ fizzled; new vaccines, at-home tests for flu ...
Profile picture of San Francisco Chronicle
The estimated percentage of people who have contracted the coronavirus ranges from 70% to 90% of the U.S. population, but it’s unclear how many have truly not ... Show more   trib.al/vwEQm7r
Profile picture of Mint (newspaper)
Finally, there's hope for long COVID treatment. Here's what it is | Mint: Ensitrelvir can shorten symptoms of mild to moderate COVID-19 by about a day
livemint.com/news/world/finally-there-s-hope-for-long-covid-treatment-here-s-what-it-is-11678192649508.html
Finally, there's hope for long COVID treatment. Here's what it is | Mint
Profile picture of The Seattle Times
WA resumes free telehealth appointments for COVID-19: Washington's COVID telehealth program previously ran from July through December last year and provided ...
seattletimes.com/seattle-news/health/wa-resumes-free-telehealth-appointments-for-covid-19/
WA resumes free telehealth appointments for COVID-19
Profile picture of St. Louis Post-Dispatch
Dr. Roach: Patient wonders why Paxlovid wasn’t prescribed for COVID: Dear Dr. Roach: In June 2022, I had a fever of 101 degrees Fahrenheit, severe sore throat ...
stltoday.com/lifestyles/health-med-fit/health/paul-donohue/dr-roach-patient-wonders-why-paxlovid-wasn-t-prescribed-for-covid/article_f0e3d78d-3998-5c76-8026-153ddad65c3a.html
Dr. Roach: Patient wonders why Paxlovid wasn’t prescribed for COVID
Profile picture of Radio Free Asia
Pfizer slashed price of Paxlovid, but China wouldn't take it: industry insider: The allegations come amid concern that officials want to push sales of a ...
rfa.org/english/news/china/covid-paxlovid-price-01132023122036.html
Pfizer slashed price of Paxlovid, but China wouldn't take it: industry ...
Profile picture of Worldcrunch
As COVID Explodes, An Inside Look At China's Gray Market Of Generic Drugs: It was only when her senile grandfather fell sick that Chen actually thought about ...
worldcrunch.com/coronavirus/china-covid-generic-drugs
As COVID Explodes, An Inside Look At China's Gray Market Of Generic Drugs
Profile picture of Reuters
Exclusive: China in talks with Pfizer for generic COVID drug: China is in talks with Pfizer Inc (PFE.N) to secure a licence that will allow domestic drugmakers ...
reuters.com/business/healthcare-pharmaceuticals/china-talks-with-pfizer-generic-covid-drug-sources-2023-01-06/
Exclusive: China in talks with Pfizer for generic COVID drug
Profile picture of South China Morning Post
Chinese drug matches Paxlovid in treating less severe Covid symptoms: Patients who took the Chinese pill, known as VV116, recovered after a median time of 4 days ...
scmp.com/news/china/science/article/3205139/chinese-drug-matches-paxlovid-treating-less-severe-covid-symptoms-study-finds
Chinese drug matches Paxlovid in treating less severe Covid symptoms
Quick Glance: Chinese health officials discuss COVID-19 with WHO
  • Reuters, Thomson Reuters' news and media section, is the world's leading multimedia news provider, reaching billions of people every day.

  • Reuters delivers corporate, financial, national, and worldwide news to professionals through desktop terminals, global media organizations, industry events, and direct to consumers.

  • Create the most compelling argument possible by leveraging authoritative material, attorney-editor knowledge, and industry-leading technology.
Profile picture of Deccan Herald
Chinese risk black market drugs as Covid surges: Desperate families searching for critical Covid-19 medication in China, faced with bare pharmacy shelves and an ...
deccanherald.com/international/world-news-politics/chinese-risk-black-market-drugs-as-covid-surges-1178063.html
Chinese risk black market drugs as Covid surges
Profile picture of San Francisco Chronicle
I got COVID but threw my Paxlovid pills in the garbage. Here’s why: As California and other states expand the use of Paxlovid, there’s little mention that the ...
sfchronicle.com/opinion/openforum/article/paxlovid-covid-side-effects-antiviral-17726139.php
I got COVID but threw my Paxlovid pills in the garbage. Here’s why
Profile picture of The Hindu
‘Fake’ Indian COVID-19 medicines flood China’s black market amid surge in cases: With the huge demand for COVID-19 medication, some fake versions of Indian ...
thehindu.com/news/international/fake-indian-covid-medicines-flood-chinas-black-market-amid-surge-in-cases/article66353027.ece
‘Fake’ Indian COVID-19 medicines flood China’s black market amid surge in ...
Profile picture of Caixin
Weekly Must-Read: China’s Road to Economic Recovery Faces Post-Covid Speed Bumps: Weekly Must-Read: China’s Road to Economic Recovery Faces Post-Covid Speed ...
caixinglobal.com/2023-01-06/weekly-must-read-chinas-road-to-economic-recovery-faces-post-covid-speed-bumps-101985752.html
Weekly Must-Read: China’s Road to Economic Recovery Faces Post-Covid Speed ...
Profile picture of South China Morning Post
As Covid surges in China, hopes for lower Paxlovid prices fade: ‘Financial and social pressure’ made it difficult to obtain the medication, report says.
scmp.com/news/china/politics/article/3207394/covid-surges-china-hopes-lower-paxlovid-prices-fade
As Covid surges in China, hopes for lower Paxlovid prices fade
Profile picture of Radio Free Asia
Asia Fact Check Lab: Is Paxlovid too expensive for China to purchase?: Verdict: MISLEADING
rfa.org/english/news/china/fact-check-01142023104123.html
Asia Fact Check Lab: Is Paxlovid too expensive for China to purchase?
Profile picture of Radio Free Asia
Chinese media hit out over pricing talks with Pfizer as COVID-19 cases skyrocket: Some 8% of people infected in the current wave have developed pneumonia ...
rfa.org/english/news/china/pricing-01102023125638.html
Chinese media hit out over pricing talks with Pfizer as COVID-19 cases ...
Profile picture of Phys.org
New COVID pill may be improvement over Paxlovid, Chinese trial suggests: COVID-19 patients could soon have a new antiviral pill they can take to guard against ...
medicalxpress.com/news/2022-12-covid-pill-paxlovid-chinese-trial.html
New COVID pill may be improvement over Paxlovid, Chinese trial suggests
Profile picture of South China Morning Post
Pfizer says Covid pills may be available in China within months: The drug maker has not yet reached a deal to provide Paxlovid through the country’s public ...
scmp.com/news/china/politics/article/3206310/pfizer-says-locally-produced-covid-pills-may-be-available-china-within-next-few-months
Pfizer says Covid pills may be available in China within months
Profile picture of WION
Covid spike in China causes citizens to turn to black market for medicines: Covid spike in China causes citizens to turn to black market for medicines
wionews.com/world/covid-spike-in-china-causes-citizens-to-turn-to-black-market-for-medicines-545593
Covid spike in China causes citizens to turn to black market for medicines
Profile picture of The Seattle Times
Should you take Paxlovid if you are mildly ill?: Very few people take the at-home antiviral medicine, but there are good reasons for certain COVID patients to ...
nytimes.com/explain/2022/coronavirus-questions/paxlovid-covid-infection-treatment
Should you take Paxlovid if you are mildly ill?
Profile picture of Caixin
Analysis: China’s Limits on Dispensing Pfizer’s Paxlovid Could Delay Treatment: Analysis: China’s Limits on Dispensing Pfizer’s Paxlovid Could Delay Treatment - ...
caixinglobal.com/2023-01-06/analysis-chinas-strict-limits-on-dispensing-pfizers-paxlovid-may-cost-lives-101986368.html
Analysis: China’s Limits on Dispensing Pfizer’s Paxlovid Could Delay ...
Profile picture of Reuters
China health app starts online sales of Pfizer's Paxlovid for COVID treatment: A Chinese healthcare platform has started selling Pfizer's (PFE ...
reuters.com/business/healthcare-pharmaceuticals/chinas-111inc-app-starts-retail-sales-pfizers-paxlovid-covid-treatment-2022-12-13/
China health app starts online sales of Pfizer's Paxlovid for COVID ...
Profile picture of WION

China is in talks with pharma-major Pfizer to secure a license that will allow domestic drugmakers to manufacture and distribute a generic version of the ... Show more   #COVID19   #Paxlovid   wionews.com/videos